comparemela.com

Page 2 - Vitro Diagnostics Medical Device News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Abbott Reports First-Quarter 2022 Results

/PRNewswire/ Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2022..

Robertb fordDrug administrationCore laboratory diagnosticsSales in core laboratoryEuropean union medical deviceAbbott laboratoriesCore laboratoryMedical devicesEstablished pharmaceuticalsAdult nutritionPediatric nutritionMolecular diagnosticsEmerging marketsHeart failureStructural heartDiabetes care

Abbott Reports Strong Fourth-Quarter 2021 Results; Issues 2022 Forecast

/PRNewswire/ Abbott (NYSE: ABT) today announced financial results for the fourth quarter and full year ended Dec. 31, 2021, and issued its financial outlook.

Abbott binaxRobertb fordInternational pediatric nutritionUs centers for medicare medicaid servicesAbbott laboratoriesEuropean union medical deviceCore laboratoryMedicaid servicesVirtual clinicAdult nutritionPediatric nutritionMolecular diagnosticsRapid diagnosticsEmerging marketsMedical devicesHeart failure

Abbott Reports Strong Fourth-Quarter 2021 Results; Issues 2022 Forecast

/PRNewswire/ Abbott (NYSE: ABT) today announced financial results for the fourth quarter and full year ended Dec. 31, 2021, and issued its financial outlook.

Abbott binaxRobertb fordInternational pediatric nutritionUs centers for medicare medicaid servicesAbbott laboratoriesEuropean union medical deviceCore laboratoryMedicaid servicesVirtual clinicAdult nutritionPediatric nutritionMolecular diagnosticsRapid diagnosticsEmerging marketsMedical devicesHeart failure

Abbott Reports Third-Quarter 2021 Results; Achieves Strong Double-Digit Earnings Growth and Raises Guidance

/PRNewswire/ Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2021. Third-quarter sales of $10.9 billion increased.

Abbott binaxAbbott cardioRobertb fordWalk vascularAbbott laboratoriesEuropean union medical deviceCore laboratoryPremarket approvalAdult nutritionPediatric nutritionMolecular diagnosticsEmerging marketsMedical devicesHeart failureStructural heartDiabetes care

Abbott Reports Third-Quarter 2021 Results; Achieves Strong Double-Digit Earnings Growth and Raises Guidance

/PRNewswire/ Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2021. Third-quarter sales of $10.9 billion increased.

Abbott binaxAbbott cardioRobertb fordWalk vascularAbbott laboratoriesEuropean union medical deviceCore laboratoryPremarket approvalAdult nutritionPediatric nutritionMolecular diagnosticsEmerging marketsMedical devicesHeart failureStructural heartDiabetes care

vimarsana © 2020. All Rights Reserved.